TCD Pharma Overview

  • Founded
  • 2005
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

TCD Pharma General Information


Developer of a drug development center designed to develop innovative therapies that address unmet medical needs. The company's center helps in treating cancer by providing an enzyme to regulate the production of phosphatidylcholine, a critical structural component required for the formation of the cell's membrane and cell proliferation, enabling patients to avail cure of Oncology at a reasonable rate.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 4 José Antonio
  • Primo de Rivera Street
  • 47001 Valladolid
  • Spain
+34 983 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TCD Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Mar-2018 000.00 Completed Out of Business
4. Grant 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 10-Jan-2012 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Mar-2010 $8.17M $11.2M Completed Startup
1. Early Stage VC 01-Jul-2005 $3.04M $3.04M Completed Startup
To view TCD Pharma’s complete valuation and funding history, request access »

TCD Pharma Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 16-Nov-2011 0000 00000 00000 Diagnostic Equipment 000 000000
To view TCD Pharma’s complete investments history, request access »

TCD Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 16-Nov-2011 0000 00000 00000 Completed
  • 2 buyers
To view TCD Pharma’s complete exits history, request access »